The abortion pill mifepristone was approved in 2000 but still faces layers of restrictions. Advocates want the FDA to permanently allow patients to receive the pill by mail instead of in person.
Only 23% of those pregnant in the U.S. have had at least one dose of a COVID-19 vaccine, statistics show. And with the delta variant surging, those who are unvaccinated are especially vulnerable.
Reproductive rights advocates want patients to be allowed to pick up mifepristone at a hospital or clinic. The drug, which was approved 20 years ago, also helps to manage miscarriages for some women.
